These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22669845)

  • 21. Eukaryotic elongation factor 2 kinase regulates the cold stress response by slowing translation elongation.
    Knight JR; Bastide A; Roobol A; Roobol J; Jackson TJ; Utami W; Barrett DA; Smales CM; Willis AE
    Biochem J; 2015 Jan; 465(2):227-38. PubMed ID: 25353634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation.
    Zhang HM; Wang F; Qiu Y; Ye X; Hanson P; Shen H; Yang D
    Biochem J; 2016 Feb; 473(4):473-85. PubMed ID: 26621875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2.
    Horman S; Beauloye C; Vertommen D; Vanoverschelde JL; Hue L; Rider MH
    J Biol Chem; 2003 Oct; 278(43):41970-6. PubMed ID: 12920134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome.
    Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T
    Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival.
    Xie J; Mikolajek H; Pigott CR; Hooper KJ; Mellows T; Moore CE; Mohammed H; Werner JM; Thomas GJ; Proud CG
    Mol Cell Biol; 2015 May; 35(10):1805-24. PubMed ID: 25776553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy.
    Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG
    Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
    De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
    EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis.
    Deng Z; Luo P; Lai W; Song T; Peng J; Wei HK
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):278-284. PubMed ID: 29024627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
    Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB
    J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA.
    Wu Y; Xie J; Jin X; Lenchine RV; Wang X; Fang DM; Nassar ZD; Butler LM; Li J; Proud CG
    Biochem J; 2020 Nov; 477(22):4367-4381. PubMed ID: 33094805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation.
    Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG
    J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation.
    Lim JKM; Samiei A; Delaidelli A; de Santis JO; Brinkmann V; Carnie CJ; Radiloff D; Hruby L; Kahler A; Cran J; Leprivier G; Sorensen PH
    Cell Death Dis; 2024 Jul; 15(7):501. PubMed ID: 39003251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
    Fu LL; Xie T; Zhang SY; Liu B
    Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance.
    Smith PR; Loerch S; Kunder N; Stanowick AD; Lou TF; Campbell ZT
    Nat Commun; 2021 Nov; 12(1):6789. PubMed ID: 34815424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol regulates eukaryotic elongation factor 2 phosphorylation via an AMP-activated protein kinase-dependent mechanism in C2C12 skeletal myocytes.
    Hong-Brown LQ; Brown CR; Huber DS; Lang CH
    J Biol Chem; 2007 Feb; 282(6):3702-12. PubMed ID: 17164244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation.
    Kaul G; Pattan G; Rafeequi T
    Cell Biochem Funct; 2011 Apr; 29(3):227-34. PubMed ID: 21394738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons.
    Weatherill DB; McCamphill PK; Pethoukov E; Dunn TW; Fan X; Sossin WS
    J Neurochem; 2011 Jun; 117(5):841-55. PubMed ID: 21426346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
    Liu R; Proud CG
    Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligase.
    Wiseman SL; Shimizu Y; Palfrey C; Nairn AC
    J Biol Chem; 2013 Jun; 288(24):17803-11. PubMed ID: 23640883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains.
    Pigott CR; Mikolajek H; Moore CE; Finn SJ; Phippen CW; Werner JM; Proud CG
    Biochem J; 2012 Feb; 442(1):105-18. PubMed ID: 22115317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.